Search Results

Diazyme Liquid Enzymatic Assay Kit is for quantitative in vitro determination of Lithium in human serum. Measurements of Lithium are carried out essentially to ensure that proper drug dosage is administered in the treatment of patient suffering from bipolar disorder and to avoid toxicity.

Not Found

The provided text (from {0} to {2}) is a 510(k) clearance letter from the FDA for a medical device called "Diazyme Liquid Stable Enzymatic Lithium Assay." This document primarily focuses on regulatory approval and equivalence to a predicate device. It does not contain specific information regarding acceptance criteria, study details, or performance metrics in the format requested.

Therefore, most of the information required to populate the table and answer the detailed questions is not present in the provided text. The document is a clearance letter, not a study report or clinical trial summary.

Here's what can be extracted and what is missing:

1. Table of Acceptance Criteria and Reported Device Performance:

2. Sample size used for the test set and the data provenance:

• Sample Size: Not specified.
• Data Provenance: Not specified (e.g., country of origin, retrospective or prospective).

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

• Number of experts: Not specified.
• Qualifications of experts: Not specified.

4. Adjudication method for the test set:

• Not specified.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, and the effect size:

• Not specified. This type of study is more common for imaging devices or AI-assisted diagnostics, not a liquid assay.

6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:

• This device is an "Enzymatic Lithium Assay," which is a lab test, not an algorithm in the typical sense of AI/ML. The concept of "standalone performance" as it applies to AI without human-in-the-loop is not relevant here. The device itself performs the assay.

7. The type of ground truth used:

• For an assay device, the "ground truth" would typically refer to a reference method or validated comparative method against which the new assay's measurements are compared. This is not specified in the document.

8. The sample size for the training set:

• Not specified. (Note: For a traditional lab assay, "training set" is not a standard term like it is for AI/ML. There would be R&D and validation work, but the concept of a "training set" for an algorithm isn't directly applicable.)

9. How the ground truth for the training set was established:

• Not specified. (As above, "training set" concept is not directly applicable.)

In summary, the provided FDA clearance letter indicates the device's regulatory pathway and its "substantially equivalent" status to a predicate device, but it does not detail the technical performance studies and their specific methodologies.

Ask a specific question about this device

Diazyme Lithium Enzymatic Assay Kit is for quantitative in vitro determination of lithium in human serum and plasma. Measurements of lithium are carried out essentially to ensure that proper drug dosage is administered in the treatment of patient suffering from bipolar disorder and to avoid toxicity.

Diazyme's lithium enzymatic assay is a spectrophotometric method, which can be adapted to most automated clinical chemistry analyzers. In Diazyme's lithium enzymatic assay, Lithium is determined spectrophotometrically through a kinetic coupling assay system involving a Diazyme's proprietary phosphatase whose activity is sensitive to lithium concentration (IC50=0.1mM). Through enzymatic coupling, the phosphatase substrate, adenosine biphosphate (PAP) is converted to hypoxanthine by a series of enzymatic reactions to generate uric acid and hydrogen peroxide (H2O2). H2O2 generated reacts with N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3-m-toluidine (EHSPT) and 4-aminoantipyrine (4-AA) in the presence of peroxidase (POD) to form a quinone dye which has maximal absorbance at 556nm. The rate of the quinine dye formation is inversely proportion to the concentration of lithium in serum samples.

The provided document (K033360) describes the Diazyme Lithium Enzymatic Assay Kit, a device for quantitative in vitro determination of lithium in human serum and plasma. The document is a 510(k) premarket notification, which seeks to demonstrate substantial equivalence to a legally marketed predicate device.

Here's an analysis of the acceptance criteria and study data based on the provided text:

1. Table of Acceptance Criteria and Reported Device Performance

The acceptance criteria are not explicitly stated in a quantitative manner as "pass/fail" thresholds. Instead, the document presents performance characteristics and asserts that they demonstrate excellent accuracy and safety/effectiveness. The comparison is primarily against a predicate device and existing methods.

2. Sample Size Used for the Test Set and Data Provenance

• Sample Size: The document mentions "clinical patient serum samples" for the comparison analysis with the predicate device but does not specify the exact number of samples used in the test set.
• Data Provenance: The document does not explicitly state the country of origin. The studies appear to be retrospective as they involve testing existing clinical patient serum samples and comparing them to established methods.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

This type of information is generally not applicable to an in vitro diagnostic (IVD) assay for a quantitative analyte like lithium. The "ground truth" for lithium concentration would be established by established analytical methods (e.g., ISE, atomic absorption spectrophotometry, predicate device) or reference materials, not by expert consensus on interpretation. Therefore, there were no experts in the sense of clinicians or radiologists used to establish ground truth.

4. Adjudication Method for the Test Set

Not applicable. As noted above, the "ground truth" is analytical, not interpretive.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not applicable. This is an in vitro diagnostic assay for quantifying a chemical analyte (lithium), not an imaging device or AI-driven diagnostic that involves human reader interpretation. Therefore, MRMC studies and "human reader improvement with AI" are not relevant to this device.

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done

This statement applies to the Diazyme Lithium Enzymatic Assay as it is a standalone assay. It provides a quantitative result for lithium concentration based solely on the enzymatic reaction and spectrophotometric measurement, without human intervention for interpretation beyond standard laboratory procedures (e.g., sample handling, instrument operation). The "algorithm" here is the chemical reaction and measurement protocol that generates the result.

7. The Type of Ground Truth Used

The ground truth was established by:

• Comparison to Legally Marketed Predicate Device: Trace Lithium Reagent (K003583).
• Comparison to Established Analytical Methods: Ion-selective electrode (ISE) method.
• Reference Materials/Spiking Studies: For linearity (implied by "wide measuring range") and interference studies, where samples were spiked with known concentrations of lithium or interfering substances.
• Known Concentrations: For precision studies (1.0mM Li+ and 2.4mM Li+).

8. The Sample Size for the Training Set

The document does not specify a training set size. For an enzymatic assay like this, "training set" is not typically a concept used in the same way as for machine learning algorithms. The assay development would involve optimizing reagents and conditions, which is analogous to "training" but doesn't involve a distinct, quantified "training set" of patient samples in the way an AI model would have.

9. How the Ground Truth for the Training Set Was Established

As explained above, a traditional "training set" with established ground truth in the context of an AI/machine learning model is not directly applicable. The "ground truth" for optimizing the assay would come from:

• Chemical principles and known reactions: The design of the enzymatic coupling system.
• Known concentrations of lithium: To establish the dose-response curve and sensitivity.
• Reference materials: For calibration and verification of the assay's performance during development.
• Comparison to existing methods: During the development and optimization phase to ensure the new assay aligns with established ways of measuring lithium.

Ask a specific question about this device